scispace - formally typeset
H

Hiroyuki Nakase

Researcher at Nara Medical University

Publications -  388
Citations -  5745

Hiroyuki Nakase is an academic researcher from Nara Medical University. The author has contributed to research in topics: Medicine & Cerebral blood flow. The author has an hindex of 34, co-authored 344 publications receiving 4793 citations. Previous affiliations of Hiroyuki Nakase include University of Mainz.

Papers
More filters
Journal ArticleDOI

Effects of Extracranial–Intracranial Bypass for Patients With Hemorrhagic Moyamoya Disease: Results of the Japan Adult Moyamoya Trial

TL;DR: Although statistically marginal, Kaplan–Meier analysis revealed the significant difference between surgical and nonsurgical group, suggesting the preventive effect of direct bypass against rebleeding.
Journal ArticleDOI

Expression of angiogenic growth factors in dural arteriovenous fistula.

TL;DR: The pathogenesis of dural AVF is still unknown, but it is concluded that angiogenic growth factors, which might be produced by the healing process due to sinus thrombosis, may participate in the genesis of dral AVF.
Journal ArticleDOI

Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation: "chemical preconditioning".

TL;DR: It is concluded that chemical preconditioning induces early-onset long-lasting tolerance against in vitro hypoxia and may be applicable as a neuroprotective strategy in humans.
Journal ArticleDOI

Analysis of Prognostic and Survival Factors Related to Treatment of Low-Grade Astrocytomas in Adults

TL;DR: Radiation therapy appears to be effective in improving the prognosis regardless of the extent of surgical resection or the p53 status, and is the most important factor in the management of low-grade astrocytomas.
Journal ArticleDOI

Potential Use of Embryonic Stem Cells for the Treatment of Mouse Parkinsonian Models: Improved Behavior by Transplantation of In Vitro Differentiated Dopaminergic Neurons from Embryonic Stem Cells

TL;DR: The purpose of the present study was to examine the efficacy of transplantation of mouse embryonic‐stem‐(ES)‐cell‐derived tyrosine hydroxylase‐positive (TH+) cells into Parkinsonian mice using behavioral tests and immunohistochemical evaluation.